Hötker Andreas, Donati Olivio F
Institut für Diagnostische und Interventionelle Radiologie, Universitätsspital Zürich, Rämistrasse 100, 8091, Zürich, Schweiz.
Radiologe. 2021 Sep;61(9):802-809. doi: 10.1007/s00117-021-00868-6. Epub 2021 Jul 2.
CLINICAL/METHODOLOGICAL ISSUE: The detection of clinically significant prostate cancers while simultaneously avoiding over-diagnosing tumors with low malignant potential is a challenge in clinical practice.
Multiparametric prostate magnetic resonance imaging (MRI) in accordance with the Prostate Imaging Reporting and Data System (PI-RADS) guidelines is accepted as standard-of-care with both urologists and radiologists.
The PI-RADS guidelines have been updated to version 2.1, including revised technical recommendations and changes to the scoring of lesions.
The PI-RADS guidelines have had great impact on the standardization of multiparametric prostate MRI and offer templates for structured reporting. This simplifies communication with the referring physician.
The new version 2.1 of the guidelines represents an evolutionary improvement of the widely accepted version 2.0. Several aspects of reporting have been revised-however, some pre-known limitations persist, which will require further refinement in the future.
临床/方法学问题：在临床实践中，既要检测出具有临床意义的前列腺癌，又要避免过度诊断低恶性潜能肿瘤，这是一项挑战。
根据前列腺影像报告和数据系统（PI-RADS）指南进行的多参数前列腺磁共振成像（MRI）被泌尿外科医生和放射科医生均视为标准治疗方法。
PI-RADS指南已更新至2.1版，包括修订后的技术建议和病变评分的变化。
PI-RADS指南对多参数前列腺MRI的标准化产生了重大影响，并提供了结构化报告模板。这简化了与转诊医生的沟通。
指南的新版本2.1是被广泛接受的版本2.0的渐进式改进。报告的几个方面已经修订——然而，一些已知的局限性仍然存在，未来需要进一步完善。
